321 results
Page 4 of 17
424B5
4vabkdug
29 Jan 21
Prospectus supplement for primary offering
5:15pm
8-K
EX-1.1
bjnzpaj 64
29 Jan 21
Adamis Pharmaceuticals Announces Proposed Public Offering of Common Stock
5:10pm
8-K
EX-99.2
dc4sh1oseswbgze
29 Jan 21
Adamis Pharmaceuticals Announces Proposed Public Offering of Common Stock
5:10pm
8-K
ejkpiznpkov93
29 Jan 21
Adamis Pharmaceuticals Announces Proposed Public Offering of Common Stock
5:10pm
8-K
EX-99.1
2pv36vhv3klg5
28 Jan 21
Updated Summary Business Information
4:26pm
424B5
94zlyr8o6vnud47 g1
28 Jan 21
Prospectus supplement for primary offering
4:08pm
8-K
EX-99.1
fxe5jpysg416bz 0h
26 Jan 21
Adamis Pharmaceuticals Provides Update On Its US Compounding Business
9:17am
8-K
EX-99.2
b5uqy2ydddkl2i2wg
5 Oct 20
Report of Independent Registered Public Accounting Firm
5:25pm
8-K
EX-99.1
is3o4d74 hf1p
5 Oct 20
Report of Independent Registered Public Accounting Firm
5:25pm
424B5
7u106riqbnjz0d59a
21 Sep 20
Prospectus supplement for primary offering
6:03am
8-K
EX-99.2
ow0 a034opbd
18 Sep 20
Adamis Pharmaceuticals Announces Proposed Public Offering of Common Stock
4:53pm
8-K
EX-1.1
9nm kqi4s
18 Sep 20
Adamis Pharmaceuticals Announces Proposed Public Offering of Common Stock
4:53pm
8-K
1cchfdaetysf19m co
18 Sep 20
Adamis Pharmaceuticals Announces Proposed Public Offering of Common Stock
4:53pm
424B5
myf8txfxp 7hrbh9
17 Sep 20
Prospectus supplement for primary offering
4:22pm
8-K
EX-10.1
gesj8ipnse7ycfs59b
24 Aug 20
Departure of Directors or Certain Officers
4:36pm